5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.51▼ | 9.49▼ | 9.41▲ | 9.20▲ | 9.32▲ |
MA10 | 9.51▼ | 9.41▲ | 9.31▲ | 9.21▲ | 9.82▼ |
MA20 | 9.50▼ | 9.30▲ | 9.20▲ | 9.40▲ | 9.05▲ |
MA50 | 9.41▲ | 9.22▲ | 9.07▲ | 9.89▼ | 8.63▲ |
MA100 | 9.31▲ | 9.07▲ | 9.24▲ | 8.80▲ | 9.11▲ |
MA200 | 9.21▲ | 9.26▲ | 9.79▼ | 8.72▲ | 9.80▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.008▼ | 0.022▲ | 0.036▲ | 0.007▲ | -0.056▼ |
RSI | 49.239▼ | 62.702▲ | 62.583▲ | 49.332▼ | 52.035▲ |
STOCH | 52.224 | 88.776▲ | 89.307▲ | 37.082 | 32.615 |
WILL %R | -84.211▼ | -20.779▲ | -13.333▲ | -44.753 | -49.680 |
CCI | -151.642▼ | 94.761 | 137.677▲ | 48.736 | -64.657 |
Tuesday, August 12, 2025 09:32 PM
Detailed price information for Relay Therapeutics Inc (RLAY-Q) from The Globe and Mail including charting and trades.
|
Monday, August 11, 2025 05:22 AM
Pegozafermin, ETNB's FGF21 analog, shows promise in late-stage trials for MASH & severe hypertriglyceridemia. Key data & potential approval ahead.
|
Sunday, August 10, 2025 06:02 PM
89Bio Inc ( ETNB) has disclosed a new risk, in the Taxation & Government Incentives category. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/08/25 | 9.32 | 9.55 | 9.185 | 9.47 | 806,017 |
15/08/25 | 9.12 | 9.31 | 8.95 | 9.23 | 1,707,712 |
14/08/25 | 9.04 | 9.33 | 8.945 | 9.10 | 1,551,073 |
13/08/25 | 9.18 | 9.50 | 9.08 | 9.14 | 2,085,167 |
12/08/25 | 8.84 | 9.245 | 8.72 | 9.04 | 1,300,412 |
11/08/25 | 9.16 | 9.16 | 8.52 | 8.77 | 1,413,209 |
08/08/25 | 8.58 | 9.21 | 8.4207 | 9.165 | 2,015,181 |
07/08/25 | 9.49 | 9.49 | 8.79 | 9.02 | 1,777,875 |
06/08/25 | 9.65 | 10.32 | 9.27 | 9.48 | 3,178,610 |
05/08/25 | 9.39 | 9.79 | 9.14 | 9.69 | 2,029,091 |
|
|
||||
|
|
||||
|
|